Clinical Trials Browser

Phase 2 × II-IIIB (T3N2) Resectable Non-small Cell Lung Cancer × 1 year × Clear all

NCT07241819 2025-11-21

Ivonescimab Monotherapy or in Combination With Chemotherapy as Neoadjuvant/Adjuvant Therapy for Resectable Non-small Cell Lung Cancer

Phase 2 Not yet recruiting

II-IIIB (T3N2) Resectable Non-small Cell Lung Cancer